Article
Mitochondrial Complex I Inhibitors Expose a Vulnerability for Selective Killing of Pten-Null Cells
1 Apr 2018
Abstract excerpt
A hallmark of advanced prostate cancer (PC) is the concomitant loss of PTEN and p53 function. To selectively eliminate such cells, we screened cytotoxic compounds on Pten −/− ; Trp53 −/− fibroblasts and their Pten -WT reference. Highly selective killing of Pten -null cells can be achieved by deguelin, a natural insecticide. Deguelin eliminates Pten -deficient cells through inhibition of mitochondrial complex I...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
